Komori
Governance4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

Independent Officer Notification Form

An Independent Officer Notification Form was submitted because proposals to elect outside officers will be put forward at the annual general meeting scheduled for 19 June 2026. One outside director and one outside Audit & Supervisory Board member are listed as new appointees, bringing the number of independent officers to 6.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
6
People (independent officers)
Wording
Definitive
How definitive the wording is.

Governance structure

Number of independent officers6Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

The form was submitted because proposals to elect outside officers will be put forward at the annual general meeting on 19 June 2026. Outside director Okanoya Chihiro (岡野谷知広) and outside Audit & Supervisory Board member Abe Yutaka (阿部裕) are listed as new appointees.

Governance structure
ItemDetails
Number of independent officers6
Changes this timeThe form was submitted because proposals to elect outside officers will be put forward at the annual general meeting on 19 June 2026. Outside director Okanoya Chihiro (岡野谷知広) and outside Audit & Supervisory Board member Abe Yutaka (阿部裕) are listed as new appointees.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because proposals for the election of outside officers will be submitted to the Annual General Meeting of Shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori